Radiotherapy and neoadjuvant versus adjuvant combined androgen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Organs at Risk Cell Line, Tumor Axilla Lymph Nodes Pelvis Rectum Esophagogastric Junction Testis Bile Ducts, Intrahepatic

Organisms2

Mice, Inbred BALB C Mice, Nude

Diseases56

Breast Neoplasms Prostatic Neoplasms Rectal Neoplasms Neoplasm Recurrence, Local Radiation Injuries Adenocarcinoma Carcinoma, Squamous Cell Esophageal Neoplasms Head and Neck Neoplasms Lymphatic Metastasis Nasopharyngeal Neoplasms Lung Neoplasms Neoplasms, Hormone-Dependent Carcinoma Brain Neoplasms Carcinoma, Ductal, Breast Androgen-Insensitivity Syndrome Neoplasm, Residual Sarcoma Bone Neoplasms Muscle Neoplasms Osteosarcoma Neoplasm Metastasis Carcinoma, Lobular Neoplasm Invasiveness Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Pancreatic Neoplasms Disease Progression Neoplasms Radiation Pneumonitis Neoplasms, Second Primary Pelvic Neoplasms Soft Tissue Neoplasms Laryngeal Neoplasms Radiodermatitis Stomach Neoplasms Hodgkin Disease Neoplasms, Radiation-Induced Carcinoma, Transitional Cell Liver Neoplasms Recurrence Thoracic Neoplasms Xerostomia Spinal Neoplasms Glioblastoma Cholangiocarcinoma Bile Duct Neoplasms Colorectal Neoplasms Glioma Retroperitoneal Neoplasms Osteoradionecrosis Carcinoma, Ductal Oropharyngeal Neoplasms Supratentorial Neoplasms

Chemicals and Drugs79

Androgens Receptors, Androgen Androgen Antagonists Adjuvants, Immunologic Fluorouracil Freund's Adjuvant Cisplatin Androgen Receptor Antagonists Dihydrotestosterone Antineoplastic Agents Doxorubicin Flutamide Taxoids Epirubicin Cyclophosphamide Testosterone Antineoplastic Agents, Hormonal Anthracyclines Nitriles Receptors, Estrogen Testosterone Congeners Receptor, erbB-2 Deoxycytidine Adjuvants, Pharmaceutic Metribolone Paclitaxel Tumor Markers, Biological Vinblastine Methotrexate Receptors, Progesterone Radiation-Sensitizing Agents Antibodies, Monoclonal, Humanized Tamoxifen Goserelin Carboplatin Fluorodeoxyglucose F18 Vincristine Dacarbazine Organoplatinum Compounds Ki-67 Antigen Antimetabolites, Antineoplastic Biomarkers, Pharmacological Leucovorin Radiopharmaceuticals Triazoles Bridged Compounds Antineoplastic Agents, Alkylating Aromatase Inhibitors Ifosfamide Androstenedione Bleomycin Prostate-Specific Antigen Antineoplastic Agents, Phytogenic Nandrolone Procarbazine Leuprolide Androstane-3,17-diol Aluminum Hydroxide Dehydroepiandrosterone 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Cyproterone Acetate Etoposide Mitomycin Antibodies, Monoclonal Tegafur Mechlorethamine Cobalt Radioisotopes Radiation-Protective Agents RNA, Messenger Lomustine Iridium Radioisotopes Steroid 17-alpha-Hydroxylase Camptothecin Antibiotics, Antineoplastic Dehydroepiandrosterone Sulfate Aromatase Cholestenone 5 alpha-Reductase Estradiol Prednisone

Analytical, Diagnostic and Therapeutic Techniques and Equipment92

Neoadjuvant Therapy Radiotherapy Chemotherapy, Adjuvant Radiotherapy, Adjuvant Radiotherapy Dosage Combined Modality Therapy Radiotherapy, Conformal Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Radiotherapy, Intensity-Modulated Neoplasm Staging Radiotherapy, High-Energy Radiotherapy Planning, Computer-Assisted Disease-Free Survival Chemoradiotherapy, Adjuvant Dose Fractionation Prognosis Chemoradiotherapy Survival Rate Survival Analysis Radiotherapy, Computer-Assisted Retrospective Studies Radiotherapy, Image-Guided Esophagectomy Brachytherapy Follow-Up Studies Mastectomy, Segmental Kaplan-Meier Estimate Mastectomy Prospective Studies Radiosurgery Dose-Response Relationship, Radiation Cystectomy Tomography, X-Ray Computed Drug Administration Schedule Positron-Emission Tomography Immunohistochemistry Lymph Node Excision Tumor Burden Prostatectomy Preoperative Care Predictive Value of Tests Remission Induction Multivariate Analysis Proportional Hazards Models Clinical Trials as Topic Feasibility Studies Neoplasm Grading Radiation Dosage Particle Accelerators Randomized Controlled Trials as Topic Cranial Irradiation Multimodal Imaging Magnetic Resonance Imaging Radiometry Palliative Care Salvage Therapy Digestive System Surgical Procedures Risk Factors Heavy Ion Radiotherapy Organ Sparing Treatments Hysterectomy Biopsy Risk Assessment Mastectomy, Modified Radical Hyperthermia, Induced Radioisotope Teletherapy Pilot Projects Treatment Failure Postoperative Care Patient Selection Cohort Studies Clinical Trials, Phase II as Topic Nomograms Lymphatic Irradiation Pancreatectomy Actuarial Analysis Sensitivity and Specificity Immunization Gastrectomy Reverse Transcriptase Polymerase Chain Reaction Biopsy, Needle Pneumonectomy Reproducibility of Results Infusions, Intravenous Analysis of Variance Hepatectomy Postoperative Period Gene Expression Profiling Pancreaticoduodenectomy Laryngectomy Sentinel Lymph Node Biopsy

Phenomena and Processes12

Time Factors Dose-Response Relationship, Radiation Radiation Tolerance Radiation Dosage Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Nomograms Drug Resistance, Neoplasm Cell Proliferation Sensitivity and Specificity Postmenopause Apoptosis

Disciplines and Occupations3

Radiation Oncology Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science5

Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Survival Rate Radiotherapy, Computer-Assisted

Health Care35

Treatment Outcome Disease-Free Survival Radiation Injuries Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Prospective Studies Dose-Response Relationship, Radiation Preoperative Care Predictive Value of Tests Multivariate Analysis Proportional Hazards Models Clinical Trials as Topic Feasibility Studies Radiation Dosage Randomized Controlled Trials as Topic Palliative Care Risk Factors Risk Assessment Pilot Projects Treatment Failure Postoperative Care Patient Selection Cohort Studies Clinical Trials, Phase II as Topic Nomograms Actuarial Analysis Sensitivity and Specificity Immunization Reproducibility of Results Age Factors Analysis of Variance Postoperative Period

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Neoadjuvant Therapy Androgens Receptors, Androgen Radiotherapy Chemotherapy, Adjuvant Radiotherapy, Adjuvant Radiotherapy Dosage Androgen Antagonists Combined Modality Therapy Radiotherapy, Conformal Adjuvants, Immunologic Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Breast Neoplasms Radiotherapy, Intensity-Modulated Neoplasm Staging Radiotherapy, High-Energy Radiotherapy Planning, Computer-Assisted Disease-Free Survival Prostatic Neoplasms Chemoradiotherapy, Adjuvant Rectal Neoplasms Fluorouracil Neoplasm Recurrence, Local Dose Fractionation Freund's Adjuvant Radiation Injuries Cisplatin Androgen Receptor Antagonists Prognosis Dihydrotestosterone Chemoradiotherapy Survival Rate Survival Analysis Radiotherapy, Computer-Assisted Retrospective Studies Radiotherapy, Image-Guided Antineoplastic Agents Doxorubicin Adenocarcinoma Flutamide Taxoids Epirubicin Esophagectomy Brachytherapy Cyclophosphamide Testosterone Follow-Up Studies Antineoplastic Agents, Hormonal Carcinoma, Squamous Cell Esophageal Neoplasms Head and Neck Neoplasms Lymphatic Metastasis Radiation Oncology Anthracyclines Nasopharyngeal Neoplasms Mastectomy, Segmental Kaplan-Meier Estimate Nitriles Receptors, Estrogen Time Factors Mastectomy Testosterone Congeners Receptor, erbB-2 Deoxycytidine Lung Neoplasms Adjuvants, Pharmaceutic Prospective Studies Metribolone Radiosurgery Paclitaxel Dose-Response Relationship, Radiation Cystectomy Tumor Markers, Biological Neoplasms, Hormone-Dependent Tomography, X-Ray Computed Vinblastine Carcinoma Brain Neoplasms Carcinoma, Ductal, Breast Androgen-Insensitivity Syndrome Prostate Drug Administration Schedule Methotrexate Receptors, Progesterone Neoplasm, Residual Sarcoma Bone Neoplasms Positron-Emission Tomography Immunohistochemistry Lymph Node Excision Radiation-Sensitizing Agents Muscle Neoplasms Antibodies, Monoclonal, Humanized Tamoxifen Tumor Burden Goserelin Radiation Tolerance Prostatectomy Osteosarcoma

No FAQ available that match "radiotherapy and neoadjuvant versus adjuvant combined androgen"